J. Gavard
Materials Chemistry · 2006–2016
A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Materials Chemistry — 16 citations into it
Whom J. Gavard trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts J. Gavard overall
Papers from J. Gavard's perspective
Ordered by how strongly the researchers J. Gavard trusts endorse each paper. Same corpus, a different order for every researcher.
- Pathophysiological consequences of VEGF-induced vascular permeability (Nature)
- The biology of VEGF and its receptors (Nature Medicine)
- Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro. (Toxicology Letters)
- Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. (Proceedings of the National Academy of Sciences of the United States of America)
- Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type. (Nature Nanotechnology)
- A pilot toxicology study of single-walled carbon nanotubes in a small sample of mice. (Nature Nanotechnology)
- In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. (Nature Nanotechnology)
- Carbon nanotubes as intracellular transporters for proteins and DNA: an investigation of the uptake mechanism and pathway. (Angewandte Chemie)
- Cancer nanotechnology: opportunities and challenges (Nature Reviews. Cancer)
- MATERIALS CHARACTERIZATION IN THE ABERRATION-CORRECTED SCANNING TRANSMISSION ELECTRON MICROSCOPE
Their papers
- VEGF controls endothelial-cell permeability by promoting the β-arrestin-dependent endocytosis of VE-cadherin (2006) — 859 citations
- Editorial :Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). DOI: 10.1080/15548627.2015.1100356;WOS:000373595400001; 2-s2.0-85013763791&;PMID: 26799652 (2016) — 1,523 citations
- Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery. (2009) — 809 citations